Aims To allow timely initiation of anticoagulation therapy for the prevention of stroke, the European guidelines on atrial fibrillation (AF) recommend remote monitoring (RM) of device-detected atrial high-rate episodes (AHREs) and progression of arrhythmia duration along pre-specified strata (6 min…<1 h, 1 h…<24 h, ≥ 24 h). We used the MATRIX registry data to assess the capability of a single-lead implantable cardioverter-defibrillator (ICD) with atrial sensing dipole (DX ICD system) to follow this recommendation in patients with standard indication for single-chamber ICD. Methods In 1841 DX ICD patients with daily automatic RM transmissions, electrograms of first device-detected AHREs per patient in and results each duration stratum were adjudicated, and the corresponding positive predictive values (PPVs) for the detections to be true atrial arrhythmia were calculated. Moreover, the incidence and progression of new-onset AF was assessed in 1451 patients with no AF history. A total of 610 AHREs ≥6 min were adjudicated. The PPV was 95.1% (271 of 285) for episodes 6min…<1 h, 99.6% (253/254) for episodes 1 h…<24 h, 100% (71/71) for episodes ≥24 h, or 97.5% for all episodes (595/ 610). The incidence of new-onset AF was 8.2% (119/1451), and in 31.1% of them (37/119), new-onset AF progressed to a higher duration stratum. Nearly 80% of new-onset AF patients had high CHA2DS2-VASc stroke risk, and 70% were not on anticoagulation therapy. Age was the only significant predictor of new-onset AF. Conclusion A 99.7% detection accuracy for AHRE ≥1 h in patients with DX ICD systems in combination with daily RM allows a reliable guideline-recommended screening for subclinical AF and monitoring of AF-duration progression.

Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole / Hindricks G.; Theuns D.A.; Bar-Lev D.; Anguera I.; Paredes F.A.A.; Arnold M.; Geller J.C.; Merkely B.; Dyrda K.M.; Perings C.; Maglia G.; Ploux S.; Meyhofer J.; Blomstrom-Lundqvist C.; Karjalainen P.; Liang Y.; Diemberger I.; Wranicz J.K.; Barr C.; Quartieri F.; Timmel T.; Bollmann A.. - In: EUROPACE. - ISSN 1099-5129. - ELETTRONICO. - 25:5(2023), pp. euad061.1-euad061.10. [10.1093/europace/euad061]

Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole

Diemberger I.;
2023

Abstract

Aims To allow timely initiation of anticoagulation therapy for the prevention of stroke, the European guidelines on atrial fibrillation (AF) recommend remote monitoring (RM) of device-detected atrial high-rate episodes (AHREs) and progression of arrhythmia duration along pre-specified strata (6 min…<1 h, 1 h…<24 h, ≥ 24 h). We used the MATRIX registry data to assess the capability of a single-lead implantable cardioverter-defibrillator (ICD) with atrial sensing dipole (DX ICD system) to follow this recommendation in patients with standard indication for single-chamber ICD. Methods In 1841 DX ICD patients with daily automatic RM transmissions, electrograms of first device-detected AHREs per patient in and results each duration stratum were adjudicated, and the corresponding positive predictive values (PPVs) for the detections to be true atrial arrhythmia were calculated. Moreover, the incidence and progression of new-onset AF was assessed in 1451 patients with no AF history. A total of 610 AHREs ≥6 min were adjudicated. The PPV was 95.1% (271 of 285) for episodes 6min…<1 h, 99.6% (253/254) for episodes 1 h…<24 h, 100% (71/71) for episodes ≥24 h, or 97.5% for all episodes (595/ 610). The incidence of new-onset AF was 8.2% (119/1451), and in 31.1% of them (37/119), new-onset AF progressed to a higher duration stratum. Nearly 80% of new-onset AF patients had high CHA2DS2-VASc stroke risk, and 70% were not on anticoagulation therapy. Age was the only significant predictor of new-onset AF. Conclusion A 99.7% detection accuracy for AHRE ≥1 h in patients with DX ICD systems in combination with daily RM allows a reliable guideline-recommended screening for subclinical AF and monitoring of AF-duration progression.
2023
Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole / Hindricks G.; Theuns D.A.; Bar-Lev D.; Anguera I.; Paredes F.A.A.; Arnold M.; Geller J.C.; Merkely B.; Dyrda K.M.; Perings C.; Maglia G.; Ploux S.; Meyhofer J.; Blomstrom-Lundqvist C.; Karjalainen P.; Liang Y.; Diemberger I.; Wranicz J.K.; Barr C.; Quartieri F.; Timmel T.; Bollmann A.. - In: EUROPACE. - ISSN 1099-5129. - ELETTRONICO. - 25:5(2023), pp. euad061.1-euad061.10. [10.1093/europace/euad061]
Hindricks G.; Theuns D.A.; Bar-Lev D.; Anguera I.; Paredes F.A.A.; Arnold M.; Geller J.C.; Merkely B.; Dyrda K.M.; Perings C.; Maglia G.; Ploux S.; Meyhofer J.; Blomstrom-Lundqvist C.; Karjalainen P.; Liang Y.; Diemberger I.; Wranicz J.K.; Barr C.; Quartieri F.; Timmel T.; Bollmann A.
File in questo prodotto:
File Dimensione Formato  
Hindricks_2023.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale (CCBYNC)
Dimensione 490.37 kB
Formato Adobe PDF
490.37 kB Adobe PDF Visualizza/Apri
euad061_supplementary_data.docx

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale (CCBYNC)
Dimensione 3.07 MB
Formato Microsoft Word XML
3.07 MB Microsoft Word XML Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/958495
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 0
social impact